Keywords: merck, kgaa, seeks, expand, erbitux, mcrc, submitted

Merck KGaA seeks to expand Erbitux in mCRC

Article | 10 December 2007

Print This

Merck KGaA has submitted an application to the European Medicines Agency (EMEA) to broaden the use of its targeted cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in